SCHEDULE 13D

Company

IOVANCE BIOTHERAPEUTICS, INC.

Filed

January 9, 2013

Accession Number

0001019687-13-000096

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →